“FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. 2022. World Bulletin of Public Health 8 (March): 67-72. https://www.scholarexpress.net/index.php/wbph/article/view/651.